| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Common Stock | Options Exercise | $52.3K | +1.4K | +4.53% | $37.47 | 32.3K | May 7, 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | -$166K | -1.4K | -4.33% | $118.84 | 30.9K | May 7, 2021 | Direct | F2 |
| transaction | XYL | Common Stock | Options Exercise | $24.3K | +503 | +1.63% | $48.33 | 31.4K | May 7, 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | -$59.6K | -503 | -1.6% | $118.57 | 30.9K | May 7, 2021 | Direct | F3 |
| transaction | XYL | Common Stock | Options Exercise | $91.7K | +1.9K | +6.14% | $48.33 | 32.8K | May 7, 2021 | Direct | F1 |
| transaction | XYL | Common Stock | Sale | -$225K | -1.9K | -5.79% | $118.82 | 30.9K | May 7, 2021 | Direct | F4 |
| transaction | XYL | Common Stock | Sale | -$213K | -1.8K | -5.82% | $118.84 | 29.1K | May 7, 2021 | Direct | F1, F5 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -1.4K | -100% | $0.00* | 0 | May 7, 2021 | Common | 1.4K | $37.47 | Direct | F6 |
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -503 | -2.86% | $0.00 | 17.1K | May 7, 2021 | Common | 503 | $48.33 | Direct | F6 |
| transaction | XYL | Stock Option (Right to Buy) | Options Exercise | $0 | -1.9K | -11.09% | $0.00 | 15.2K | May 7, 2021 | Common | 1.9K | $48.33 | Direct | F6 |
| Id | Content |
|---|---|
| F1 | The sale was made pursuant to a 10b5-1 plan adopted by the reporting person on December 16, 2020. |
| F2 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F3 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F4 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.37. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F5 | This price represents the weighted average price per share of common stock (each, a "Share") of Xylem Inc. (the "Issuer"). Shares were executed at a range of prices from $118.05 to $119.36. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price |
| F6 | These options are fully vested and exercisable. |